#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA2114764	F	PubChem BioAssay. Counterscreen for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5): Luminescence-based biochemical high throughput dose response assay to identify inhibitors of Hepatocyte nuclear factor 4 (HNF4) dimerization. (Class of assay: confirmatory)	Homo sapiens	234		cell-based format	PubChem BioAssays
2.	ALA1961843	B	Effect on HNF4A(NR2A1) dependent reporter activity in HEK293 cells at 20 uM		2		cell-based format	Scientific Literature
3.	ALA1015274	B	Increase in transcriptional activity of HNF-4alpha ligand binding domain expressed in human Hep G2 cells co-transfected with Gal4-DBD by luciferase reporter gene assay		2		cell-based format	Scientific Literature
4.	ALA1065467	F	Agonist activity at human full length HNF4alpha nuclear receptor expressed in human HepG2/C3A cells co-transfected with LexADBD assessed as increase in transcriptional activity after 16 hrs by beta-galactosidase one hybrid assay	Homo sapiens	8		cell-based format	Scientific Literature
5.	ALA1065471	F	Agonist activity at human full length HNF4alpha nuclear receptor expressed in human HepG2/C3A cells co-transfected with LexADBD assessed as increase in transcriptional activity at 9.3 uM by beta-galactosidase one hybrid assay relative to control	Homo sapiens	3		cell-based format	Scientific Literature
6.	ALA1065340	F	Agonist activity at human full length HNF4alpha nuclear receptor expressed in human HepG2/C3A cells co-transfected with LexADBD assessed as increase in transcriptional activity at 12.5 uM by beta-galactosidase one hybrid assay relative to control	Homo sapiens	2		cell-based format	Scientific Literature
7.	ALA1065341	F	Agonist activity at human full length HNF4alpha nuclear receptor expressed in human HepG2/C3A cells co-transfected with LexADBD assessed as increase in transcriptional activity at 18.7 uM by beta-galactosidase one hybrid assay relative to control	Homo sapiens	1		cell-based format	Scientific Literature
8.	ALA1065342	F	Agonist activity at human full length HNF4alpha nuclear receptor expressed in human HepG2/C3A cells co-transfected with LexADBD assessed as increase in transcriptional activity at 6.2 uM by beta-galactosidase one hybrid assay relative to control	Homo sapiens	1		cell-based format	Scientific Literature
9.	ALA1065343	F	Agonist activity at human full length HNF4alpha nuclear receptor expressed in human HepG2/C3A cells co-transfected with LexADBD assessed as increase in transcriptional activity at 100 uM by beta-galactosidase one hybrid assay relative to control	Homo sapiens	1		cell-based format	Scientific Literature
10.	ALA1065345	F	Agonist activity at AF1 deleted human HNF4alpha7 nuclear receptor expressed in human HepG2/C3A cells co-transfected with LexADBD assessed as increase in transcriptional activity after 16 hrs by beta-galactosidase one hybrid assay	Homo sapiens	1		cell-based format	Scientific Literature
11.	ALA1065346	F	Agonist activity at human HNF4alpha7 nuclear receptor LBDdetaF expressed in human HepG2/C3A cells co-transfected with LexADBD assessed as increase in transcriptional activity after 16 hrs by beta-galactosidase one hybrid assay	Homo sapiens	1		cell-based format	Scientific Literature
12.	ALA1065347	B	Stabilization of thermal denaturation-induced conformational change in human HNF4alpha nuclear receptor ligand binding domain assessed as change in transition temperature by thermofluor assay	Homo sapiens	1		single protein format	Scientific Literature
13.	ALA1065348	B	Activation of HNFalpha transcriptional activity in human HepG3/C3A cells transfected with ApoB-luc assessed as activation of luciferase reporter gene after 24 hrs	Homo sapiens	1		cell-based format	Scientific Literature
14.	ALA1065349	B	Activation of HNFalpha transcriptional activity in human HepG3/C3A cells transfected with ApoCIII-luc assessed as activation of luciferase reporter gene after 24 hrs	Homo sapiens	1		cell-based format	Scientific Literature
15.	ALA1648535	B	Inhibition of HNF4alpha mRNA expression in human HepG2 cells after 24 hrs by RT-PCR analysis	Homo sapiens	6		cell-based format	Scientific Literature
16.	ALA1648536	B	Inhibition of HNF4alpha mRNA expression in human HepG2 cells after 24 hrs by Western blotting	Homo sapiens	6		cell-based format	Scientific Literature
17.	ALA3720922	B	Displacement of radiolabeled methyl-4-[5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-3-ethyloxy-2-naphthalenyl]benzoyl benzoate from HNF4alpha (unknown origin)	Homo sapiens	5		single protein format	Patent Bioactivity Data
18.	ALA3720927	B	Displacement of [3H]methyl4-[5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-3-ethyloxy-2-naphthalenyl]benzoyl benzoate from HNF4alpha (unknown origin) by radioligand binding assay	Homo sapiens	20		single protein format	Patent Bioactivity Data
19.	ALA4629614	B	Agonist activity at recombinant human pFA-CMV-fused HNF4alpha LBD expressed in HEK293T cells transfected with pFR-luciferase plasmid and pRL-SV40 plasmid at 0.01 to 10 uM incubated for 14 to 16 hrs by dual glo luciferase reporter gene assay	Homo sapiens	3		cell-based format	Scientific Literature
20.	ALA4629615	B	Agonist activity at recombinant human pFA-CMV-fused HNF4alpha LBD expressed in HEK293T cells transfected with pFR-luciferase plasmid and pRL-SV40 plasmid at 0.001 to 0.3 uM incubated for 14 to 16 hrs by dual glo luciferase reporter gene assay	Homo sapiens	1		cell-based format	Scientific Literature